Founder & President, Ring14 USA
Yssa DeWoody, PhD, is the Co-founder and Director of Ring14 USA, a non-profit focused on improving the quality of life for those impacted by anomalies on the 14th chromosome through research, advocacy, and community support. This work is a labor of love motivated by her third daughter, Marie, who was born with the ultra-rare Ring Chromosome 14 Syndrome which is characterized by early onset intractable epilepsy, global developmental delays, intellectual disabilities, and a host of other challenges. Yssa also sits on the board of Ring14 International, which oversees and coordinates research initiatives for neurodevelopmental syndromes of the 14th chromosome. She wants to be part of the solution that makes life brighter and easier for these affected children and their families.
Yssa DeWoody is true believer in collaboration as actualized by her commitment to several consortiums including the Rare Epilepsy Network, Epilepsy Leadership Council, Epilepsy Learning Healthcare Systems, and the Commission for Neurodevelopmental CNVs.
"It is my vision that REN can play a critical role in helping each of the member organizations, especially the smaller ones with less infrastructure and smaller budgets, to get to an effective therapy in a shorter timeframe than the organization could do working in isolation."
REN Vice Chair
Executive Director, Dup15q Alliance
Vanessa Vogel-Farley is the Executive Director of the Dup15q Alliance and also serves serves as the Data Collection Platform Lead for RARE-X. Previously, she was at the University of Minnesota, Center for Neurobehavioral Development. She has also served as the Clinical Research Coordinator for the Division of Developmental Medicine Laboratory of Cognitive Neuroscience, Boston Children’s Hospital, working on collaborations with scientists from MIT and Harvard examining several clinical populations, including autism. She possesses 15 years of experience in data collection methods as well as expertise in non-profit and research operations, patient advocacy and support, non-profit management, and broad knowledge of child development neuroscience/psychology research and administration.
"Having sat on the coordinating committee for the past 2 years and all of the things we have learned and
heard feed back from the network members, I hope to help bring forward a clear reason and function of
REN, both internally to the network members but externally in the larger rare epilepsy space."
REN Projects Oversight
Senior Director of Clinical Research
Kathleen Farrell is the Senior Director of the Epilepsy Learning Healthcare System (ELHS) as part of the National Office team of the Epilepsy Foundation. She is a physician by training, having completed her medical education in Dublin, Ireland. She came to the Foundation in 2015, and previously worked as the Senior Director of Clinical Research. It was in that role that she first worked with the Rare Epilepsy Network (REN).
CEO, Angelman Syndrome Foundation
Amanda Moore has served in a senior leadership position for the YMCA of Greater Indianapolis for the past eighteen years. She started her Y career working in after school programs serving at risk youth and then transitioned into an Executive Director role. She has her Masters in Leadership Development as well as a Certificate in Fundraising from the Indiana University School of Philanthropy. In 2015, Amanda and her husband Adam were blessed with adopting twin boys Jackson and Baden. In 2016, Jackson was diagnosed with Angelman Syndrome and at that time Amanda vowed to take action to do what she could for Jackson and individuals like him. She served on the Angelman Syndrome Board for one year and now is serving in the role as CEO of the Angelman Syndrome Foundation.
"How can we work together to serve a larger purpose and goal. I hope to work together with like minded leaders to work hard to support the team to getting to the finish line of our goals. I have learned so much from others already, and would love to engage more."
REN Website & Communications
Assoc. Dir. of Research,
Priya Balasubramanian, PhD, is Associate Director of Research at CURE Epilepsy where she oversees their investigator-initiated grants programs. In this role, she manages CURE Epilepsy’s research portfolio, supports new research initiatives, and acts as a scientific liaison to other teams.
Priya obtained her doctorate degree in Molecular Biology from the University of Southern California and has over 10 years of experience leading research studies to understand and develop therapies for rare diseases, including Laron Syndrome and Prader-Willi Syndrome.
"An improved understanding of rare epilepsy diagnoses, treatments and best practices amongst
caregivers and providers, as well as driving research to understanding common mechanisms across the rare epilepsies so we can expedite therapy development."
Grants & Fundraising
Tuesdi Dyer is the Executive Director of CFC International and currently lives in Arizona with her husband Brent, and two sons, Ellis and Emmett. Emmett was diagnosed with CFC Syndrome at 4 months old.
Tuesdi is a Certified Fundraising Executive (CFRE), and has dedicated more than two decades of her career to nonprofit leadership in fundraising, operations and capacity growth. Previously, she served as a Director at the Nonprofit Leadership Center, where she provided coaching for nonprofit leaders and life cycle management. She has also been a university and community instructor in nonprofit business planning.
Tuesdi has served on numerous non-profit boards focused on the arts, health equity, education and child welfare, and is a former President of the Junior League of St. Petersburg. She is currently on the Global Genes Foundation Alliance Leadership Council, and has served on the Advisory Council of Johns’ Hopkins All Children’s Hospital in St. Petersburg, Florida. She has been recognized by the Chamber of Commerce and Tampa Bay Business Journal for her career and volunteer work. She was also a 2020 nominee for Global Genes' Rare Champion of Hope.
Tuesdi holds a B.A. in Political Science from Texas A&M University.
"I believe it's imperative that capacity for the organization be well planned so that
a wealth of institutional knowledge is shared rather than existing among a few."
Ilene Penn Miller consults with major national nonprofit organizations on strategic, program, and operation planning. Ilene counsels the national Epilepsy Foundation, TESS Research Foundation and other clients. She is the Epilepsy Leadership Council Advocacy Co-Chair on the 2020 NINDS Curing the Epilepsies Conference. She also serves as the Director for the Rare Epilepsy Network (REN) – composed of 70+ rare epilepsy organizations committed to improving outcomes for patients through collaborative research. Ilene is a former Advisor on the NIH National Institute for Neurological Disorders and Stroke (NINDS) Advisory Council (2013-2017) and an active member of the Epilepsy Leadership Council (ELC) and Epilepsy Learning Health System (ELHS). Previously, Ilene co-founded and is past President of Hope for Hypothalamic Hamartomas (hopeforhh.org). Ilene served as Executive Director of the Cure for Lymphoma Foundation and as a Senior Associate at Podesta Associates where she counseled a coalition of major national cancer advocacy organizations and implemented legislative, executive branch, grassroots, and media strategies to increase federal cancer appropriations. Ilene earned a B.S. in communications from Boston University; a J.D. from the Columbus School of Law at Catholic University of America (Washington, D.C); an LL.M. in advocacy from Georgetown University Law Center (Washington, D.C) and a Nonprofit Management Certificate from Georgetown University (Washington, DC). She has recently published the Rare Epilepsy Landscape Analysis (RELA) and an editorial in Epilepsy & Behavior - Raring For Change.
"New rare epilepsy diagnoses are exploding as genetic testing, imaging, and other diagnostics improve. REN brings all of these voices under one network where we can collectively increase public awareness, encourage research towards improved outcomes and cure, and leverage scarce resources!"
Previous Members of REN Coordinating Committee
Hillary Savoi, The Cute Syndrome (2019-2021)
Kris Pierce, Genetic Epilepsy Team Australia (2019-2021)